Agenus (AGEN) Cash from Operations (QoQ) (2010 - 2026)
Agenus (AGEN) Cash from Operations (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.57 Bn | 466.77 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.01 Bn | 114.76 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn |
| 10 | Agenus | 232.39 Mn | 197.39 Mn | 33.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -116.33% |
| Dec 31, 2025 | -12.76% |
| Sep 30, 2025 | 27.12% |
| Jun 30, 2025 | 21.06% |
| Mar 31, 2025 | 10.59% |
| Dec 31, 2024 | 46.24% |
| Sep 30, 2024 | -39.58% |
| Jun 30, 2024 | 0.03% |
| Mar 31, 2024 | 5.47% |
| Dec 31, 2023 | 38.06% |
| Sep 30, 2023 | -8.64% |
| Jun 30, 2023 | -2.59% |
| Mar 31, 2023 | -23.63% |
| Dec 31, 2022 | -47.05% |
| Sep 30, 2022 | 25.92% |
| Jun 30, 2022 | 17.06% |
| Mar 31, 2022 | -128.51% |
| Dec 31, 2021 | -117.45% |
| Sep 30, 2021 | 336.47% |
| Jun 30, 2021 | -29.98% |